Reciprocal regulation of ARPP-16 by PKA and MAST-3 kinases provides a cAMP-regulated switch in protein phosphatase 2A inhibition

  1. Veronica Musante
  2. Lu Li
  3. Jean Kanyo
  4. Tukiet T Lam
  5. Christopher M Colangelo
  6. Shuk Kei Cheng
  7. Harrison Brody
  8. Paul Greengard
  9. Nicolas Le Novère
  10. Angus C Nairn  Is a corresponding author
  1. Yale University School of Medicine, United States
  2. Babraham Institute, United Kingdom
  3. Yale University School Medicine, United States
  4. The Rockefeller University, United States

Abstract

ARPP-16, ARPP-19, and ENSA are inhibitors of protein phosphatase PP2A. ARPP-19 and ENSA phosphorylated by Greatwall kinase inhibit PP2A during mitosis. ARPP-16 is expressed in striatal neurons where basal phosphorylation by MAST3 kinase inhibits PP2A and regulates key components of striatal signaling. The ARPP-16/19 proteins were discovered as substrates for PKA, but the function of PKA phosphorylation is unknown. We find that phosphorylation by PKA or MAST3 mutually suppresses the ability of the other kinase to act on ARPP-16. Phosphorylation by PKA also acts to prevent inhibition of PP2A by ARPP-16 phosphorylated by MAST3. Moreover, PKA phosphorylates MAST3 at multiple sites resulting in its inhibition. Mathematical modeling highlights the role of these three regulatory interactions to create a switch-like response to cAMP. Together the results suggest a complex antagonistic interplay between the control of ARPP-16 by MAST3 and PKA that creates a mechanism whereby cAMP mediates PP2A disinhibition.

Article and author information

Author details

  1. Veronica Musante

    Department of Psychiatry, Yale University School of Medicine, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Lu Li

    Babraham Institute, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  3. Jean Kanyo

    W.M. Keck Biotechnology Resource Laboratory, Yale University School Medicine, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Tukiet T Lam

    W.M. Keck Biotechnology Resource Laboratory, Yale University School Medicine, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Christopher M Colangelo

    W.M. Keck Biotechnology Resource Laboratory, Yale University School Medicine, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Shuk Kei Cheng

    Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Harrison Brody

    Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Paul Greengard

    Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Nicolas Le Novère

    Babraham Institute, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6309-7327
  10. Angus C Nairn

    Department of Psychiatry, Yale University School of Medicine, New Haven, United States
    For correspondence
    angus.nairn@yale.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7075-0195

Funding

National Institute on Drug Abuse (DA018343)

  • Angus C Nairn

National Institutes of Health (DA10044 NS091336)

  • Veronica Musante
  • Paul Greengard
  • Angus C Nairn

State of Connecticut Department of Mental Health and Addiction Services

  • Angus C Nairn

Brain and Behavior Research Foundation

  • Veronica Musante

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2017, Musante et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,777
    views
  • 326
    downloads
  • 25
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Veronica Musante
  2. Lu Li
  3. Jean Kanyo
  4. Tukiet T Lam
  5. Christopher M Colangelo
  6. Shuk Kei Cheng
  7. Harrison Brody
  8. Paul Greengard
  9. Nicolas Le Novère
  10. Angus C Nairn
(2017)
Reciprocal regulation of ARPP-16 by PKA and MAST-3 kinases provides a cAMP-regulated switch in protein phosphatase 2A inhibition
eLife 6:e24998.
https://doi.org/10.7554/eLife.24998

Share this article

https://doi.org/10.7554/eLife.24998

Further reading

    1. Computational and Systems Biology
    Jun Ren, Ying Zhou ... Qiyuan Li
    Research Article

    Manifold-learning is particularly useful to resolve the complex cellular state space from single-cell RNA sequences. While current manifold-learning methods provide insights into cell fate by inferring graph-based trajectory at cell level, challenges remain to retrieve interpretable biology underlying the diverse cellular states. Here, we described MGPfactXMBD, a model-based manifold-learning framework and capable to factorize complex development trajectories into independent bifurcation processes of gene sets, and thus enables trajectory inference based on relevant features. MGPfactXMBD offers a more nuanced understanding of the biological processes underlying cellular trajectories with potential determinants. When bench-tested across 239 datasets, MGPfactXMBD showed advantages in major quantity-control metrics, such as branch division accuracy and trajectory topology, outperforming most established methods. In real datasets, MGPfactXMBD recovered the critical pathways and cell types in microglia development with experimentally valid regulons and markers. Furthermore, MGPfactXMBD discovered evolutionary trajectories of tumor-associated CD8+ T cells and yielded new subtypes of CD8+ T cells with gene expression signatures significantly predictive of the responses to immune checkpoint inhibitor in independent cohorts. In summary, MGPfactXMBD offers a manifold-learning framework in scRNA-seq data which enables feature selection for specific biological processes and contributing to advance our understanding of biological determination of cell fate.

    1. Computational and Systems Biology
    2. Genetics and Genomics
    Daniel Hui, Scott Dudek ... Marylyn D Ritchie
    Research Article

    Apart from ancestry, personal or environmental covariates may contribute to differences in polygenic score (PGS) performance. We analyzed the effects of covariate stratification and interaction on body mass index (BMI) PGS (PGSBMI) across four cohorts of European (N = 491,111) and African (N = 21,612) ancestry. Stratifying on binary covariates and quintiles for continuous covariates, 18/62 covariates had significant and replicable R2 differences among strata. Covariates with the largest differences included age, sex, blood lipids, physical activity, and alcohol consumption, with R2 being nearly double between best- and worst-performing quintiles for certain covariates. Twenty-eight covariates had significant PGSBMI–covariate interaction effects, modifying PGSBMI effects by nearly 20% per standard deviation change. We observed overlap between covariates that had significant R2 differences among strata and interaction effects – across all covariates, their main effects on BMI were correlated with their maximum R2 differences and interaction effects (0.56 and 0.58, respectively), suggesting high-PGSBMI individuals have highest R2 and increase in PGS effect. Using quantile regression, we show the effect of PGSBMI increases as BMI itself increases, and that these differences in effects are directly related to differences in R2 when stratifying by different covariates. Given significant and replicable evidence for context-specific PGSBMI performance and effects, we investigated ways to increase model performance taking into account nonlinear effects. Machine learning models (neural networks) increased relative model R2 (mean 23%) across datasets. Finally, creating PGSBMI directly from GxAge genome-wide association studies effects increased relative R2 by 7.8%. These results demonstrate that certain covariates, especially those most associated with BMI, significantly affect both PGSBMI performance and effects across diverse cohorts and ancestries, and we provide avenues to improve model performance that consider these effects.